Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV 1

Clinical and Experimental Allergy

Volumn 42, Issue 5, 2012, Pages 782-791

  Agbetile, J ^a,b   Fairs, A ^a   Desai, D ^a,b   Hargadon, B ^b   Bourne, M ^b   Mutalithas, K ^b   Edwards, R ^b   Morley, J P ^a   Monteiro, W R ^b   Kulkarni, N S ^b   Green, R H ^b   Pavord, I D ^b   Bradding, P ^a,b   Brightling, C E ^a,b   Wardlaw, A J ^a,b   Pashley, C H ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Airflow obstruction; Asthma; Fungal allergy; Fungal culture

Indexed keywords

ALLERGEN; DEXAMETHASONE; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASTHMA; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PENICILLIUM; PRIORITY JOURNAL; SPUTUM;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; FUNGI; HUMANS; IMMUNOGLOBULIN E; MACROPHAGES; MALE; MIDDLE AGED; PHAGOCYTOSIS; SPUTUM; YOUNG ADULT;

EID: 84859990716     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.03987.x     Document Type: Article

References (53)

1. Wardlaw AJ, Brightling C, Green R et al. Eosinophils in asthma and other allergic diseases. Br Med Bull 2000; 56:985-1003.
2. Holgate ST Pathogenesis of asthma. Clin Exp Allergy 2008; 38:872-97.
3. Green BJ, Sercombe JK, Tovey ER Fungal fragments and undocumented conidia function as new aeroallergen sources. J Allergy Clin Immunol 2005; 115:1043-8.
4. Denning DW, O'Driscoll BR, Hogaboam CM et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27:615-26.
5. Rosas I, McCartney HA, Payne RW et al. Analysis of the relationships between environmental factors (aeroallergens, air pollution, and weather) and asthma emergency admissions to a hospital in Mexico City. Allergy 1998; 53:394-401.
6. Dales RE, Cakmak S, Judek S et al. The role of fungal spores in thunderstorm asthma. Chest 2003; 123:745-50.
7. Black PN, Udy AA, Brodie SM Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000; 55:501-4.
8. Rosenberg M, Patterson R, Mintzer R et al. Clinical and immunological criteria for diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977; 86:405-14.
9. Greenberger PA Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110:685-92.
10. Tillie-Leblond L, Tonnel A-B Allergic bronchopulmonary aspergillosis. Allergy 2005; 60:1004-13.
11. Vlahakis NE, Aksamit TR Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 2001; 76:930-8.
12. Simon-Nobbe B, Denk U, Poll V et al. The spectrum of fungal allergy. Int Arch Allergy Immunol 2008; 145:58-86.
13. O'Driscoll BR, Powell G, Chew F et al. Comparison of skin prick tests with specific serum immunoglobin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy 2009; 39:1677-83.
14. Denning DW, O'Driscoll BR, Powell G et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 2009; 179:11-8.
15. Fairs A, Agbetile J, Hargadon B et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med 2010; 182:1362-8.
16. Menzies D, Holmes L, McCumesky G et al. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy 2011; 66:679-85.
17. Moss RB Allergic bronchopulmonary aspergillosis. Clin Rev Allergy Immunol 2002; 23:87-104.
18. Sudfeld CR, Dasenbrook EC, Merz WG et al. Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis. J Cyst Fibros 2010; 9:110-6.
19. Pihet M, Carrere J, Cimon B et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis - a review. Med Mycol 2009; 47:387-97.
20. Malo JL, Hawkins R, Pepys J Studies in chronic allergic bronchopulmonary aspergillosis. 1. Clinical and physiological findings. Thorax 1977; 32:254-61.
21. British Thoracic Society Scottish Intercollegiate Guizdelines Network. British guideline on the management of asthma. Thorax 2008; 63(Suppl. 4): iv1-121.
22. Miller MR, Hankinson J, Brusasco V et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-38.
23. Brightling CE, Monteiro W, Ward R et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356:1480-5.
24. Brightling CE, Symon FA, Birring SS et al. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003; 58:528-32.
25. Pizzichini E, Pizzichini MMM, Efthimiadis A et al. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 1996; 9:1174-80.
26. Pavord ID, Pizzichini MMM, Pizzichini E, Hargreave FE The use of induced sputum to investigate airway inflammation. Thorax 1997; 52:498-501.
27. Campbell CK, Johnson EM, Philpot CM, Warnock DW Identification of pathogenic fungi. London: Public Health Laboratory Service, 1996.
28. Issakainen J, Jalava J, Saari J, Campbell CK Relationship of Scedosporium prolificans with Petriella confirmed by partial LSU rDNA sequences. Mycol Res 1999; 103:1179-84.
29. White TJ, Bruns T, Lee S, Taylor J Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ eds. PCR protocols: a guide to methods and applications. San Diego, New York, Boston, London, Sydney, Tokyo, Toronto: Academic Press, 1990:315-22.
30. Hansell DM, Bankier AA, MacMahon H et al. Fleischner society: glossary of terms tor thoracic imaging. Radiology 2008; 246:697-722.
31. Schaffner A Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing the responsiveness to gamma-interferon. J Clin Invest 1985; 76:1755-64.
32. Health Protection Agency. Investigation of bronchoalveolar lavage, sputum and associated specimens. National Standard Method BSOP57 2009 issue 2.3. Available at (accessed 3 March 2010).
33. Pashley CH, Fairs A, Morley JP et al. Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med Mycol 2011; doi: 10.3109/13693786.2011.615762.
34. Sercombe JK, Green BJ, Tovey ER Recovery of germinating fungal conidia from the nasal cavity after environmental exposure. Aerobiologia 2006; 22:295-304.
35. Lionakis MS, Kontoyiannis DP Glucocorticoids and invasive fungal infections. Lancet 2003; 362:1828-38.
36. Waldorf AR, Levitz SM, Diamond RD In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus J Infect Dis 1984; 150:752-60.
37. Ng TTC, Robson GD, Denning DW Hydrocortisone-enhanced growth of Aspergillus spp - implications for pathogenesis. Microbiology 1994; 140:2475-9.
38. Nagano Y, Elborn JS, Miller BC et al. Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis. Med Mycol 2010; 48:166-76.
39. Mok T, Koehler AP, Yu MY et al. Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia. J Clin Microbiol 1997; 35:2654-6.
40. Horre R, Gilges S, Breig P et al. Case report. Fungaemia due to Penicillium piceum, a member of the Penicillium marneffei complex. Mycoses 2001; 44:502-4.
41. Santos PE, Piontelli E, Shea YR et al. Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease. Med Mycol 2006; 44:749-53.
42. Grossman CE, Fowler A Paecilomyces: emerging fungal pathogen. Chest 2005; 128:425S-425S.
43. Rickerts V, Just-Nubling G, Konrad F et al. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis 2006; 25:8-13.
44. Verweij PE, van Kasteren M, van de Nes J et al. Fatal pulmonary infection caused by the basidiomycete Hormographiella aspergillata J Clin Microbiol 1997; 35:2675-8.
45. Barron MA, Sutton DA, Veve R et al. Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol 2003; 41:5302-7.
46. Fairs A, Wardlaw AJ, Thompson JR, Pashley CH Guidelines on ambient intramural airborne fungal spores. J Investig Allergol Clin Immunol 2010; 20:490-8.
47. Ren P, Jankun TM, Belanger K et al. The relation between fungal propagules in indoor air and home characteristics. Allergy 2001; 56:419-24.
48. Vernon DRH, Allan F Environmental factors in allergic bronchopulmonary aspergillosis. Clin Allergy 1980; 10:217-27.
49. Dumestre-Perard C, Lamy B, Aldebert D et al. Aspergillus conidia activate the complement by the mannan-binding lectin C2 bypass mechanism. J Immunol 2008; 181:7100-5.
50. Soeria-Atmadja D, Onell A, Borga A IgE sensitization to fungi mirrors fungal phylogenetic systematics. J Allergy Clin Immunol 2010; 125:1379-86.
51. Shaw D, Berry M, Hargadon B et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest 2007; 132:1871-5.
52. Schmid-Grendelmeier P, Fluckiger S, Disch R et al. IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 2005; 115:1068-75.
53. Crameri R, Faith A, Hemmann S et al. Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus J Exp Med 1996; 184:265-70.